what is the fda deadline for glp-1 drugs issued 25 warning letters to telehealth companies false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Proposes Ban on Bulk

You complete a short online intake about your health and goals

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Eli Lilly have a new, once-monthly GLP1/GIP agonist (Brenipatide) and they're running some fascinating trials with it Smoking cessation, bipolar disorder, schizophrenia, opioid use disorder, depression, alcohol use disorder, and asthma

Here is a list of approved and pending new GLP-1 agonists class of medications that can help manage Type 2 diabetes and obesity.

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

are the major companies operating in this market.